Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...

Huahei Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), ...

Americans are particularly concerned with avoiding animal products. Indeed, a recent study published in the Postgraduate ...

At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap ...

The phase 2 trial of CT-388, a once-weekly subcutaneous injection acquired as part of its $2.7 billion takeover of Carmot ...

The UK has lost its measles elimination status, according to the World Health Organization (WHO), after recording 2,911 ...

In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...

That is according to the Wall Street Journal, which has said MSD failed to reach an agreement with Revolution on a fair price ...

A new technology elucidated yesterday in the journal Nature has the potential to be a leap forward in DNA synthesis, allowing ...

In the evolving landscape of healthcare professional (HCP) engagement, face-to-face interactions remain a cornerstone. They ...

A hole has been blown in Bausch Health's late-stage pipeline, after a follow-up to its top-selling drug product Xifaxan ...